LFSVSMRNA• 28 Days (Normalized)
LFS vs MRNA (LEIFRAS Co. Ltd. vs Moderna Inc.)
Showing Closing Date Range from Aug, 14 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
LFS Performance $2.19
-9.5%
LEIFRAS Co. Ltd.
Normalized Baseline0.00%
MRNA Performance $143.97
+127.37%
Moderna Inc.
Normalized Baseline0.00%
Alpha Spread Margin MRNA LEADS
-136.87%
MRNA outperforming by 136.87%
LFSMRNA
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
LFS MRNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | LFS Price | LFS Gain (%) | MRNA Price | MRNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $2.19 | -9.50% | $143.97 | +127.37% | -136.87% |
| Sep 10, 2026 | $2.17 | -10.33% | $136.62 | +115.76% | -126.09% |
| Sep 09, 2026 | $2.17 | -10.33% | $135.61 | +114.17% | -124.50% |
| Sep 08, 2026 | $2.13 | -11.98% | $140.33 | +121.62% | -133.60% |
| Sep 04, 2026 | $2.18 | -9.92% | $145.55 | +129.86% | -139.78% |
| Sep 03, 2026 | $2.23 | -7.85% | $148.87 | +135.11% | -142.96% |
| Sep 02, 2026 | $2.15 | -11.16% | $150.81 | +138.17% | -149.33% |
| Sep 01, 2026 | $2.20 | -9.09% | $154.27 | +143.64% | -152.73% |
| Aug 31, 2026 | $2.24 | -7.44% | $140.34 | +121.64% | -129.08% |
| Aug 28, 2026 | $2.27 | -6.20% | $137.99 | +117.92% | -124.12% |
| Aug 27, 2026 | $2.28 | -5.79% | $142.77 | +125.47% | -131.26% |
| Aug 26, 2026 | $2.27 | -6.20% | $149.66 | +136.36% | -142.56% |
| Aug 25, 2026 | $2.31 | -4.55% | $158.83 | +150.84% | -155.39% |
| Aug 24, 2026 | $2.27 | -6.20% | $138.89 | +119.35% | -125.55% |
| Aug 21, 2026 | $2.40 | -0.83% | $145.13 | +129.20% | -130.03% |
Page 1 of 2